These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 9725232

  • 21. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F, Basse PH, Hokland M.
    Nat Immun; ; 15(2-3):134-46. PubMed ID: 9162263
    [Abstract] [Full Text] [Related]

  • 22. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
    Cerboni C, Achour A, Wärnmark A, Mousavi-Jazi M, Sandalova T, Hsu ML, Cosman D, Kärre K, Carbone E.
    Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
    [Abstract] [Full Text] [Related]

  • 23. Natural killer clones recognize specific soluble HLA class I molecules.
    Carbone E, Terrazzano G, Colonna M, Tuosto L, Piccolella E, Franksson L, Palazzolo G, Pérez-Villar JJ, Fontana S, Kärre K, Zappacosta S.
    Eur J Immunol; 1996 Mar; 26(3):683-9. PubMed ID: 8605938
    [Abstract] [Full Text] [Related]

  • 24. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
    Brutkiewicz RR, Klaus SJ, Welsh RM.
    Nat Immun; 1992 Mar; 11(4):203-14. PubMed ID: 1421956
    [Abstract] [Full Text] [Related]

  • 25. Vaccinia virus modulation of natural killer cell function by direct infection.
    Kirwan S, Merriam D, Barsby N, McKinnon A, Burshtyn DN.
    Virology; 2006 Mar 30; 347(1):75-87. PubMed ID: 16387342
    [Abstract] [Full Text] [Related]

  • 26. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro.
    Sun LL, Han Y, Chen JH, Yao YQ.
    Fertil Steril; 2008 Dec 30; 90(6):2398-405. PubMed ID: 18243178
    [Abstract] [Full Text] [Related]

  • 27. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
    Lindsley MD, Torpey DJ, Rinaldo CR.
    J Immunol; 1986 Apr 15; 136(8):3045-51. PubMed ID: 2420881
    [Abstract] [Full Text] [Related]

  • 28. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
    Zhang C, Tian Z, Hou G.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 15; 23(5):369-72. PubMed ID: 11810763
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.
    Llano M, Gumá M, Ortega M, Angulo A, López-Botet M.
    Eur J Immunol; 2003 Oct 15; 33(10):2744-54. PubMed ID: 14515258
    [Abstract] [Full Text] [Related]

  • 30. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG, Crew MD, Forte P, Baumann BC, Seebach JD.
    Xenotransplantation; 2007 Mar 15; 14(2):126-34. PubMed ID: 17381687
    [Abstract] [Full Text] [Related]

  • 31. The development and characterization of a natural killer cell-resistant human renal cell carcinoma cell line.
    Ernstoff MS, Jaffee EM, Oeler T.
    Nat Immun; 1992 Mar 15; 11(1):17-25. PubMed ID: 1351770
    [Abstract] [Full Text] [Related]

  • 32. NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines.
    Carr WH, Little AM, Mocarski E, Parham P.
    Clin Immunol; 2002 Nov 15; 105(2):126-40. PubMed ID: 12482387
    [Abstract] [Full Text] [Related]

  • 33. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
    Seebach JD, Comrack C, Germana S, LeGuern C, Sachs DH, DerSimonian H.
    J Immunol; 1997 Oct 01; 159(7):3655-61. PubMed ID: 9317166
    [Abstract] [Full Text] [Related]

  • 34. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR, Smith BR.
    J Clin Invest; 1985 Sep 01; 76(3):913-8. PubMed ID: 2995450
    [Abstract] [Full Text] [Related]

  • 35. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A, Prevosto C, Zancolli M, Canevali P, Musso A, Zocchi MR.
    Ann N Y Acad Sci; 2007 Aug 01; 1109():47-57. PubMed ID: 17785290
    [Abstract] [Full Text] [Related]

  • 36. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
    Schmidt RE, Bartley G, Levine H, Schlossman SF, Ritz J.
    J Immunol; 1985 Aug 01; 135(2):1020-5. PubMed ID: 3924996
    [Abstract] [Full Text] [Related]

  • 37. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH, Heagy W, Martz E.
    J Immunol; 1985 Jan 01; 134(1):70-7. PubMed ID: 3880579
    [Abstract] [Full Text] [Related]

  • 38. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L, Mingari MC.
    Hum Immunol; 2004 May 01; 65(5):437-45. PubMed ID: 15172443
    [Abstract] [Full Text] [Related]

  • 39. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debré P, Vieillard V.
    AIDS; 2008 Jan 11; 22(2):217-26. PubMed ID: 18097224
    [Abstract] [Full Text] [Related]

  • 40. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.
    Eur J Immunol; 2003 Jun 11; 33(6):1657-66. PubMed ID: 12778484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.